4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-057520
Options or other derivatives
- Chief Operating Officer acquired 474,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Beetham Thomas W. Chief Operating Officer | 2023-10-30 | Grant or award · Stock Option (Right to Buy) | +474,400 | 474,400 | D | ||
Loading xslF345X05/ownership.xml…